Work

A Phase I Clinical and Pharmacology Study Using Amifostine as a Radioprotector in Dose-escalated Whole Liver Radiation Therapy

Year: 2012

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2011.10.020

Authors: Mary Feng, Mary Feng, David E. Smith, Daniel P. Normolle, James A. Knol, Charlie C. Pan, Edgar Ben-Josef, Zheng Lu, Meihua R. Feng, Meihua R. Feng, Jun Chen, William Ensminger, Theodore S. Lawrence

Institutions: University of Michigan, Michigan Medicine, University of Pittsburgh

Language: English

Topic: Effects of Radiation Exposure

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1534093387, G55794565, Optimization of High Dose Conformal Therapy, G7385167997, G741073515

OpenAlex ID: W2010316145

FWCI: 2.445

Cites: 22

Cited by: 42

Related to: 10